Overview

Our understanding of myeloproliferative neoplasms (MPN) disorders, a group of clonal haematological malignancies characterized by excessive accumulation of one or more myeloid cell lineages, has grown considerably over the past four decades.Myeloproliferative Neoplasms offers a detailed evidence-based guide to MPNs in an easily accessible format, structured to facilitate learning specialist information by presenting core information in 'bite size' chunks. Each chapter summarises the state-of-the art preclinical and clinical knowledge, and its impact on the clinical management of patients with MPNs. This practical guide, written by experts in the field, is essential reading for oncologists, haematologists, and other health care professionals interested in the field of MPNs.

Full Product Details

Author:   Tariq I. Mughal (Professor of Medicine in Hematology/Oncology, Professor of Medicine in Hematology/Oncology, Tufts University Medical Center, Boston, MA, USA) ,  Tiziano Barbui (Professor of Hematology, Professor of Hematology, Scientific Director, Research Foundation Ospedali Riuniti di Bergamo, Italy)
Publisher:   Oxford University Press
Imprint:   Oxford University Press
Dimensions:   Width: 10.00cm , Height: 1.40cm , Length: 18.00cm
Weight:   0.164kg
ISBN:  

9780198744214

ISBN 10:   0198744218
Pages:   352
Publication Date:   24 September 2020
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   To order  
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Table of Contents

1: Tariq I. Mughal and Tiziano Barbui: History of the myeloproliferative neoplasms 2: Srinivas K. Tantravahi, Jamshid S. Khorashad, and Michael W.Deininger: Genomic landscape of myeloproliferative neo-plasms 3: Angela G. Fleischman and Richard A. Van Etten: Pathogenesis of myeloproliferative neoplasms 4: Hans Michael Kvasnicka and Jüergen Thiele: Haematopathology of myeloproliferative neoplasms 5: Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Simona Soverini, and Gianantonio Rosti: Prognostic factors of chronic myeloid leukaemia 6: Paola Guglielmelli and Alessandro M. Vannucchi: Molecular risk stratification of Myeloproliferative Neoplasms 7: Tariq I. Mughal: Chronic myeloid leukaemia 8: Tiziano Barbui and Guido Finazzi: Polycythaemia vera 9: Claire Harrison, Yan Beauverd, and Donal McLorran: Myelofibrosis 10: Carlos Besses, Beatriz Bellosillo, and Alberto Alvarez-Larrán: Essential thrombocythemia 11: Jason Gotlib: Systemic mastocytosis 12: Eric Padron, David Sallman, Tariq I. Mughal, and Alan F. List: Myelodysplastic syndromes/myeloproliferative neoplasms 13: Andreas Reiter and Nicholas C. P. Cross: Eosinophilia-associated myeloproliferative neoplasms 14: Omar Abdelwahab, Raajit Rampal, Catriona Jamieson, and Tariq I. Mughal: Transformation of myeloproliferative neoplasms to acute leukaemia 15: Daniel Egan and Jerald P. Radich: Monitoring efforts in myeloproliferative neoplasms 16: Alessandro Rambaldi and Nicholas Kröger: Stem cell transplantation for BCR-ABL1-postive and negative myeloproliferative neoplasms 17: Holly L. Geyer, Deepti Radia, Nicholas Sarlis, and Ruben A. Mesa: Assessment of disease burden in patients with myeloproliferative neoplasms 18: Giovanni Barosi and Gianni Tognoni: Clinical trials in bcr-abl1-negative myeloproliferative neo-plasms

Reviews

This practical guide, written by experts in the field, is essential reading for oncologists, haematologists, and other health care professionals interested in the field of MPNs. * Anticancer Research *

Author Information

Following training in haematology/oncology and stem cell transplantation at Imperial College London, Professor Tariq I Mughal has held haematology/oncology leadership roles in cancer centres of excellence in London, Manchester and Denver. From an early stage in his career, he has been interested in precision haematologic cancer medicine and breast cancer. He now practices in Boston and London, and is a member of many learned societies. He is a professor of medicine and founder of Alpine Oncology Foundation dedicated to improve haematologic cancer care in economically challenged countries. He has published over 130 peer-reviewed scientific publications, 30 book chapters and authored/edited 13 books on cancers. Following training inhematology/oncology in Padova, Professor Tiziano Barbui was appointed initially as a Professor, and later as the head of the department of Haematology at the (then) Ospedale Riuniti, and now Papa Giovanni XXIII, in Bergamo (Italy). He is a past-President of the Italian Society of Haematology, and chair of the Lupus Anticoagulant Subcommittee of the International Society of Thrombosis and Haemostasis. He currently leads the Italian GIMEMA group and is the co-chair of the European-Leukemia-Net working group on Myeloproliferative Disorders. He has published over 450 peer-reviewed scientific publications and authored/edited several books and chapters.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions